Viktor Steimle

6.4k total citations · 2 hit papers
45 papers, 4.4k citations indexed

About

Viktor Steimle is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Viktor Steimle has authored 45 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Viktor Steimle's work include Immune Cell Function and Interaction (33 papers), T-cell and B-cell Immunology (29 papers) and Immunotherapy and Immune Responses (23 papers). Viktor Steimle is often cited by papers focused on Immune Cell Function and Interaction (33 papers), T-cell and B-cell Immunology (29 papers) and Immunotherapy and Immune Responses (23 papers). Viktor Steimle collaborates with scholars based in Switzerland, Germany and Canada. Viktor Steimle's co-authors include Bernard Mach, Walter Reith, Madeleine Zufferey, L. Otten, Annick Mühlethaler‐Mottet, Barbara Lisowska‐Grospierre, Claire-Anne Siegrist, Eduardo Martínez-Soria, Séverine Bontron and Krzysztof Masternak and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Viktor Steimle

45 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

1993 725 citations Viktor Steimle, L. Otten et al. profile →
Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA

1994 714 citations Viktor Steimle, Barbara Lisowska‐Grospierre et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Viktor Steimle Switzerland	31	3.4k	1.3k	847	344	327	45	4.4k
Sophie M. Lehar United States	18	2.7k 0.8×	1.3k 1.0×	644 0.8×	222 0.6×	227 0.7×	22	3.9k
Philip G. Ashton‐Rickardt United States	29	3.4k 1.0×	1.2k 0.9×	615 0.7×	178 0.5×	364 1.1×	57	4.5k
Susan John United Kingdom	32	2.5k 0.7×	1.6k 1.2×	1.5k 1.8×	544 1.6×	369 1.1×	51	4.6k
Hans Christian Probst Germany	30	2.3k 0.7×	1.4k 1.1×	1.1k 1.2×	311 0.9×	224 0.7×	104	4.1k
Hironobu Asao Japan	35	2.6k 0.8×	1.4k 1.1×	1.2k 1.5×	338 1.0×	388 1.2×	85	4.5k
Martin R. Hodge United States	29	2.9k 0.9×	1.7k 1.3×	947 1.1×	391 1.1×	264 0.8×	41	4.7k
Frank Leithäuser Germany	35	1.8k 0.5×	1.7k 1.3×	990 1.2×	410 1.2×	325 1.0×	79	4.0k
Shinsuke Taki Japan	28	2.7k 0.8×	800 0.6×	916 1.1×	282 0.8×	237 0.7×	64	3.5k
Rémy Bosselut United States	38	3.2k 1.0×	1.6k 1.2×	893 1.1×	339 1.0×	282 0.9×	82	4.5k
Kurt Bachmaier Canada	26	1.8k 0.5×	1.1k 0.8×	592 0.7×	255 0.7×	179 0.5×	32	3.1k

Countries citing papers authored by Viktor Steimle

Since Specialization

Citations

This map shows the geographic impact of Viktor Steimle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Steimle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Steimle more than expected).

Fields of papers citing papers by Viktor Steimle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Steimle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Steimle. The network helps show where Viktor Steimle may publish in the future.

Co-authorship network of co-authors of Viktor Steimle

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Steimle. A scholar is included among the top collaborators of Viktor Steimle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Steimle. Viktor Steimle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rodriguez, Galaxia M., Diwakar Bobbala, Daniel Serrano, et al.. (2016). NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8⁺ T lymphocytes. OncoImmunology. 5(6). e1151593–e1151593. 67 indexed citations

Steimle, Viktor, et al.. (2012). MARCH1 down-regulation in IL-10-activated B cells increases MHC class II expression. Cytokine. 59(1). 27–30. 26 indexed citations

Côté, Marie‐Hélène, Marie‐Claude Bourgeois‐Daigneault, Fangming Xiu, et al.. (2009). Sorting of MHC Class II Molecules into Exosomes through a Ubiquitin‐Independent Pathway. Traffic. 10(10). 1518–1527. 67 indexed citations

Thibodeau, Jacques, Marie‐Claude Bourgeois‐Daigneault, Jessy Tremblay, et al.. (2008). Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. European Journal of Immunology. 38(5). 1225–1230. 138 indexed citations

Steimle, Viktor, L. Otten, Madeleine Zufferey, & Bernard Mach. (2007). Pillars Article: Complementation Cloning of an MHC Class II Transactivator Mutated in Hereditary MHC Class II Deficiency (or Bare Lymphocyte Syndrome). Cell 1993. 75: 135–146.. The Journal of Immunology. 178(11). 6677–6688. 6 indexed citations

Petter, Michaela, Takeshi Egawa, Kirsten Laule-Kilian, et al.. (2005). Runx3 Regulates Integrin αE/CD103 and CD4 Expression during Development of CD4−/CD8+ T Cells. The Journal of Immunology. 175(3). 1694–1705. 107 indexed citations

Ehlers, Marc, Kirsten Laule-Kilian, Michaela Petter, et al.. (2003). Morpholino Antisense Oligonucleotide-Mediated Gene Knockdown During Thymocyte Development Reveals Role for Runx3 Transcription Factor in CD4 Silencing During Development of CD4−/CD8+ Thymocytes. The Journal of Immunology. 171(7). 3594–3604. 44 indexed citations

Hake, Sandra B., et al.. (2003). N‐terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA. European Journal of Immunology. 33(8). 2337–2347. 38 indexed citations

Hake, Sandra B., et al.. (2003). Comparison of the transcriptional regulation of classical and non‐classical MHC class II genes. European Journal of Immunology. 33(9). 2361–2371. 16 indexed citations

10.

Wiszniewski, Wojciech, Marie‐Claude Fondanèche, Françoise Le Deist, et al.. (2001). Mutation in the Class II trans- Activator Leading to a Mild Immunodeficiency. The Journal of Immunology. 167(3). 1787–1794. 30 indexed citations

11.

Otten, L., Viktor Steimle, Séverine Bontron, & Bernard Mach. (1998). Quantitative control of MHC class II expression by the transactivator CIITA. European Journal of Immunology. 28(2). 473–478. 105 indexed citations

12.

Bontron, Séverine, Viktor Steimle, Catherine Ucla, Martha M. Eibl, & Bernard Mach. (1997). Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Human Genetics. 99(4). 541–546. 46 indexed citations

13.

Steimle, Viktor, Walter Reith, & Bernard Mach. (1996). Major Histocompatibility Complex Class II Deficiency: A Disease of Gene Regulation. Advances in immunology. 61. 327–340. 12 indexed citations

14.

Steimle, Viktor & Bernard Mach. (1995). Complementation cloning of mammalian transcriptional regulators: the example of MHC class II gene regulators. Current Opinion in Genetics & Development. 5(5). 646–651. 11 indexed citations

15.

Lu, Yanmei, et al.. (1995). RB and A novel E2F‐1 binding protein in MHC class II deficient B‐cell lines and normal IFN‐γ induction of the class II transactivator ciita in class II non‐inducible RB‐defective tumor lines. International Journal of Cancer. 62(4). 461–465. 12 indexed citations

16.

Kern, Ilse, Viktor Steimle, Claire‐Anne Siegrist, & Bernard Mach. (1995). The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. International Immunology. 7(8). 1295–1299. 92 indexed citations

17.

Silacci, Paolo, et al.. (1994). Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.. The Journal of Experimental Medicine. 180(4). 1329–1336. 133 indexed citations

18.

Martínez-Soria, Eduardo, Viktor Steimle, Pascale Beffy, et al.. (1994). An HLA-DRB α-helix motif shared by DR11 and DR8 alleles is implicated in the pluriallelic restriction of peptide-specific T-cell lines. Human Immunology. 40(4). 279–290. 11 indexed citations

19.

Urlacher, A., J.‐M. Tiercy, Michael Schlesier, et al.. (1989). A T-cell clone recognizing an MLC stimulating epitope located on the DRw11β1 chain. Human Immunology. 26(4). 321–332. 3 indexed citations

20.

Steimle, Viktor, Ari Hinkkanen, Michael Schlesier, & Jörg T. Epplen. (1988). A novel HLA-DR ? I sequence from the DRw11 haplotype. Immunogenetics. 28(3). 208–210. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact